Håkansson, E., Norberg, H., Själander, S., & Lindmark, K. Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population. Wiley.
Chicago Style (17th ed.) CitationHåkansson, Erik, Helena Norberg, Sara Själander, and Krister Lindmark. Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population. Wiley.
MLA (9th ed.) CitationHåkansson, Erik, et al. Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population. Wiley.
Warning: These citations may not always be 100% accurate.